Similar articles

• Biomarkers of altered coagulation and fibrinolysis as measures of disease activity in active inflammatory bowel disease: a gender-stratified, cohort analysis.

  Shen J, Ran ZH, Zhang Y, Cai Q, Yin HM, Zhou XT, Xiao SD. Shen J, et al. Thromb Res. 2009 Feb;123(4):604-11. doi: 10.1016/j.thromres.2008.04.004. Epub 2008 May 21. Thromb Res. 2009. PMID: 18499234
• PAI-1 and TAFI in inflammatory bowel disease: the yin and yang of the fibrinolytic system.

  Danese S, Papa A. Danese S, et al. Eur J Gastroenterol Hepatol. 2008 Sep;20(9):826-8. doi: 10.1097/MEG.0b013e3282faa769. Eur J Gastroenterol Hepatol. 2008. PMID: 18794594 Review.
• Coagulation and fibrinolysis in inflammatory bowel disease and in giant cell arteritis.

  Vrij AA, Rijken J, van Wersch JW, Stockbrügger RW. Vrij AA, et al. Pathophysiol Haemost Thromb. 2003 Mar-Apr;33(2):75-83. doi: 10.1159/000073850. Pathophysiol Haemost Thromb. 2003. PMID: 14624048
• Plasma thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 levels in inflammatory bowel disease.

  Koutroubakis IE, Sfiridaki A, Tsiolakidou G, Coucoutsi C, Theodoropoulou A, Kouroumalis EA. Koutroubakis IE, et al. Eur J Gastroenterol Hepatol. 2008 Sep;20(9):912-6. doi: 10.1097/MEG.0b013e3282faa759. Eur J Gastroenterol Hepatol. 2008. PMID: 18794606
• Hypercoagulability and Platelet Abnormalities in Inflammatory Bowel Disease.

  Senchenkova E, Seifert H, Granger DN. Senchenkova E, et al. Semin Thromb Hemost. 2015 Sep;41(6):582-9. doi: 10.1055/s-0035-1556590. Epub 2015 Aug 13. Semin Thromb Hemost. 2015. PMID: 26270113 Review.